HEADER HYDROLASE 09-SEP-13 4C4X TITLE CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE HYDROXYLASE 2 TITLE 2 COMPLEXED WITH C9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL EPOXIDE HYDROLASE 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: EPOXIDE HYDROXYLASE DOMAIN RESIDUES 230-555; COMPND 5 SYNONYM: BIFUNCTIONAL EPOXIDE HYDROXYLASE 2, CYTOSOLIC EPOXIDE COMPND 6 HYDROLASE 2, CEH, EPOXIDE HYDRATASE, SOLUBLE EPOXIDE HYDROLASE, SEH, COMPND 7 LIPID-PHOSPHATE PHOSPHATASE; COMPND 8 EC: 3.3.2.10, 3.1.3.76; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET16B KEYWDS HYDROLASE, DRUG DESIGN, MULTIPLE BINDING MODES EXPDTA X-RAY DIFFRACTION AUTHOR J.PILGER,A.MAZUR,P.MONECKE,H.SCHREUDER,B.ELSHORST,T.LANGER, AUTHOR 2 A.SCHIFFER,I.KRIMM,M.WEGSTROTH,D.LEE,G.HESSLER,K.-U.WENDT,S.BECKER, AUTHOR 3 C.GRIESINGER REVDAT 7 20-DEC-23 4C4X 1 REMARK REVDAT 6 24-FEB-21 4C4X 1 REMARK REVDAT 5 15-MAY-19 4C4X 1 REMARK REVDAT 4 08-MAY-19 4C4X 1 REMARK REVDAT 3 10-JUN-15 4C4X 1 JRNL REVDAT 2 29-APR-15 4C4X 1 JRNL REVDAT 1 01-OCT-14 4C4X 0 JRNL AUTH J.PILGER,A.MAZUR,P.MONECKE,H.SCHREUDER,B.ELSHORST, JRNL AUTH 2 S.BARTOSCHEK,T.LANGER,A.SCHIFFER,I.KRIMM,M.WEGSTROTH,D.LEE, JRNL AUTH 3 G.HESSLER,K.WENDT,S.BECKER,C.GRIESINGER JRNL TITL A COMBINATION OF SPIN DIFFUSION METHODS FOR THE JRNL TITL 2 DETERMINATION OF PROTEIN-LIGAND COMPLEX STRUCTURAL JRNL TITL 3 ENSEMBLES. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 54 6511 2015 JRNL REFN ISSN 1433-7851 JRNL PMID 25877959 JRNL DOI 10.1002/ANIE.201500671 REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 34823 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.210 REMARK 3 FREE R VALUE TEST SET COUNT : 2512 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.24 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2990 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2383 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2774 REMARK 3 BIN R VALUE (WORKING SET) : 0.2364 REMARK 3 BIN FREE R VALUE : 0.2635 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 216 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5061 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 445 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.96960 REMARK 3 B22 (A**2) : 11.59460 REMARK 3 B33 (A**2) : -8.62500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.46590 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.287 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.319 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.211 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.304 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.210 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.909 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5267 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7141 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1797 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 122 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 755 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5267 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 629 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 2 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6357 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.94 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.13 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.31 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY. THE INHIBITOR HAS REMARK 3 BEEN MODELED IN TWO ORIENTATIONS REMARK 4 REMARK 4 4C4X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1290058281. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35085 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.170 REMARK 200 RESOLUTION RANGE LOW (A) : 44.310 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3OTQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP. 1 UL PROTEIN SOLUTION (8 REMARK 280 MG/ML SEH IN 100 MM NAPO2, PH 7.4, 5 MM DTT AND 15% GLYCEROL) REMARK 280 WAS MIXED WITH 1 UL RESERVOIR SOLUTION (100 MM TRIS-HCL, PH 8.3, REMARK 280 26% PEG4000 AND 200 MM LI2SO4 AND EQUILIBRATED AT 20C. CRYSTALS REMARK 280 APPEARED IN ABOUT 2 WEEKS, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.93500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 230 REMARK 465 SER A 231 REMARK 465 CYS A 232 REMARK 465 ASN A 233 REMARK 465 PRO A 234 REMARK 465 ASN A 548 REMARK 465 PRO A 549 REMARK 465 PRO A 550 REMARK 465 VAL A 551 REMARK 465 VAL A 552 REMARK 465 SER A 553 REMARK 465 LYS A 554 REMARK 465 MET A 555 REMARK 465 THR B 230 REMARK 465 SER B 231 REMARK 465 CYS B 232 REMARK 465 ASN B 233 REMARK 465 ASN B 548 REMARK 465 PRO B 549 REMARK 465 PRO B 550 REMARK 465 VAL B 551 REMARK 465 VAL B 552 REMARK 465 SER B 553 REMARK 465 LYS B 554 REMARK 465 MET B 555 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO B 234 CG CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 269 -155.87 -105.31 REMARK 500 ASP A 335 -117.99 59.52 REMARK 500 ASN A 359 -40.95 72.89 REMARK 500 SER A 418 61.98 -112.37 REMARK 500 CYS A 423 132.65 69.42 REMARK 500 GLU A 424 124.51 -8.05 REMARK 500 ALA A 425 -47.61 4.68 REMARK 500 LEU A 480 106.89 38.59 REMARK 500 LEU A 499 67.87 -105.24 REMARK 500 HIS A 513 38.40 -99.22 REMARK 500 PRO B 268 75.58 -100.53 REMARK 500 GLU B 269 -156.83 -99.78 REMARK 500 ASP B 335 -118.98 58.44 REMARK 500 ASN B 359 -45.83 69.92 REMARK 500 PHE B 381 31.36 -92.64 REMARK 500 VAL B 422 63.37 -108.88 REMARK 500 CYS B 423 -44.84 -153.32 REMARK 500 PHE B 429 59.91 -104.75 REMARK 500 LEU B 480 117.25 -10.76 REMARK 500 HIS B 513 32.35 -97.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2111 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH B2213 DISTANCE = 5.91 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE W9M A 1548 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE W9M B 1548 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C4Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE HYDROXYLASE 2 REMARK 900 COMPLEXED WITH A4 REMARK 900 RELATED ID: 4C4Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE HYDROXYLASE 2 REMARK 900 COMPLEXED WITH A8 DBREF 4C4X A 230 555 UNP P34913 HYES_HUMAN 230 555 DBREF 4C4X B 230 555 UNP P34913 HYES_HUMAN 230 555 SEQRES 1 A 326 THR SER CYS ASN PRO SER ASP MET SER HIS GLY TYR VAL SEQRES 2 A 326 THR VAL LYS PRO ARG VAL ARG LEU HIS PHE VAL GLU LEU SEQRES 3 A 326 GLY SER GLY PRO ALA VAL CYS LEU CYS HIS GLY PHE PRO SEQRES 4 A 326 GLU SER TRP TYR SER TRP ARG TYR GLN ILE PRO ALA LEU SEQRES 5 A 326 ALA GLN ALA GLY TYR ARG VAL LEU ALA MET ASP MET LYS SEQRES 6 A 326 GLY TYR GLY GLU SER SER ALA PRO PRO GLU ILE GLU GLU SEQRES 7 A 326 TYR CYS MET GLU VAL LEU CYS LYS GLU MET VAL THR PHE SEQRES 8 A 326 LEU ASP LYS LEU GLY LEU SER GLN ALA VAL PHE ILE GLY SEQRES 9 A 326 HIS ASP TRP GLY GLY MET LEU VAL TRP TYR MET ALA LEU SEQRES 10 A 326 PHE TYR PRO GLU ARG VAL ARG ALA VAL ALA SER LEU ASN SEQRES 11 A 326 THR PRO PHE ILE PRO ALA ASN PRO ASN MET SER PRO LEU SEQRES 12 A 326 GLU SER ILE LYS ALA ASN PRO VAL PHE ASP TYR GLN LEU SEQRES 13 A 326 TYR PHE GLN GLU PRO GLY VAL ALA GLU ALA GLU LEU GLU SEQRES 14 A 326 GLN ASN LEU SER ARG THR PHE LYS SER LEU PHE ARG ALA SEQRES 15 A 326 SER ASP GLU SER VAL LEU SER MET HIS LYS VAL CYS GLU SEQRES 16 A 326 ALA GLY GLY LEU PHE VAL ASN SER PRO GLU GLU PRO SER SEQRES 17 A 326 LEU SER ARG MET VAL THR GLU GLU GLU ILE GLN PHE TYR SEQRES 18 A 326 VAL GLN GLN PHE LYS LYS SER GLY PHE ARG GLY PRO LEU SEQRES 19 A 326 ASN TRP TYR ARG ASN MET GLU ARG ASN TRP LYS TRP ALA SEQRES 20 A 326 CYS LYS SER LEU GLY ARG LYS ILE LEU ILE PRO ALA LEU SEQRES 21 A 326 MET VAL THR ALA GLU LYS ASP PHE VAL LEU VAL PRO GLN SEQRES 22 A 326 MET SER GLN HIS MET GLU ASP TRP ILE PRO HIS LEU LYS SEQRES 23 A 326 ARG GLY HIS ILE GLU ASP CYS GLY HIS TRP THR GLN MET SEQRES 24 A 326 ASP LYS PRO THR GLU VAL ASN GLN ILE LEU ILE LYS TRP SEQRES 25 A 326 LEU ASP SER ASP ALA ARG ASN PRO PRO VAL VAL SER LYS SEQRES 26 A 326 MET SEQRES 1 B 326 THR SER CYS ASN PRO SER ASP MET SER HIS GLY TYR VAL SEQRES 2 B 326 THR VAL LYS PRO ARG VAL ARG LEU HIS PHE VAL GLU LEU SEQRES 3 B 326 GLY SER GLY PRO ALA VAL CYS LEU CYS HIS GLY PHE PRO SEQRES 4 B 326 GLU SER TRP TYR SER TRP ARG TYR GLN ILE PRO ALA LEU SEQRES 5 B 326 ALA GLN ALA GLY TYR ARG VAL LEU ALA MET ASP MET LYS SEQRES 6 B 326 GLY TYR GLY GLU SER SER ALA PRO PRO GLU ILE GLU GLU SEQRES 7 B 326 TYR CYS MET GLU VAL LEU CYS LYS GLU MET VAL THR PHE SEQRES 8 B 326 LEU ASP LYS LEU GLY LEU SER GLN ALA VAL PHE ILE GLY SEQRES 9 B 326 HIS ASP TRP GLY GLY MET LEU VAL TRP TYR MET ALA LEU SEQRES 10 B 326 PHE TYR PRO GLU ARG VAL ARG ALA VAL ALA SER LEU ASN SEQRES 11 B 326 THR PRO PHE ILE PRO ALA ASN PRO ASN MET SER PRO LEU SEQRES 12 B 326 GLU SER ILE LYS ALA ASN PRO VAL PHE ASP TYR GLN LEU SEQRES 13 B 326 TYR PHE GLN GLU PRO GLY VAL ALA GLU ALA GLU LEU GLU SEQRES 14 B 326 GLN ASN LEU SER ARG THR PHE LYS SER LEU PHE ARG ALA SEQRES 15 B 326 SER ASP GLU SER VAL LEU SER MET HIS LYS VAL CYS GLU SEQRES 16 B 326 ALA GLY GLY LEU PHE VAL ASN SER PRO GLU GLU PRO SER SEQRES 17 B 326 LEU SER ARG MET VAL THR GLU GLU GLU ILE GLN PHE TYR SEQRES 18 B 326 VAL GLN GLN PHE LYS LYS SER GLY PHE ARG GLY PRO LEU SEQRES 19 B 326 ASN TRP TYR ARG ASN MET GLU ARG ASN TRP LYS TRP ALA SEQRES 20 B 326 CYS LYS SER LEU GLY ARG LYS ILE LEU ILE PRO ALA LEU SEQRES 21 B 326 MET VAL THR ALA GLU LYS ASP PHE VAL LEU VAL PRO GLN SEQRES 22 B 326 MET SER GLN HIS MET GLU ASP TRP ILE PRO HIS LEU LYS SEQRES 23 B 326 ARG GLY HIS ILE GLU ASP CYS GLY HIS TRP THR GLN MET SEQRES 24 B 326 ASP LYS PRO THR GLU VAL ASN GLN ILE LEU ILE LYS TRP SEQRES 25 B 326 LEU ASP SER ASP ALA ARG ASN PRO PRO VAL VAL SER LYS SEQRES 26 B 326 MET HET W9M A1548 28 HET W9M B1548 28 HETNAM W9M 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYL-UREA FORMUL 3 W9M 2(C9 H10 CL2 N2 O) FORMUL 5 HOH *445(H2 O) HELIX 1 1 SER A 270 ARG A 275 5 6 HELIX 2 2 TYR A 276 ALA A 284 1 9 HELIX 3 3 ILE A 305 TYR A 308 5 4 HELIX 4 4 CYS A 309 LEU A 324 1 16 HELIX 5 5 ASP A 335 TYR A 348 1 14 HELIX 6 6 SER A 370 ASN A 378 1 9 HELIX 7 7 PHE A 381 PHE A 387 1 7 HELIX 8 8 GLY A 391 ASN A 400 1 10 HELIX 9 9 ASN A 400 PHE A 409 1 10 HELIX 10 10 THR A 443 LYS A 455 1 13 HELIX 11 11 PHE A 459 ASN A 464 1 6 HELIX 12 12 ASN A 468 LYS A 478 1 11 HELIX 13 13 VAL A 500 GLN A 505 5 6 HELIX 14 14 HIS A 506 TRP A 510 5 5 HELIX 15 15 TRP A 525 LYS A 530 1 6 HELIX 16 16 LYS A 530 ALA A 546 1 17 HELIX 17 17 SER B 270 ARG B 275 5 6 HELIX 18 18 TYR B 276 ALA B 284 1 9 HELIX 19 19 ILE B 305 TYR B 308 5 4 HELIX 20 20 CYS B 309 LEU B 324 1 16 HELIX 21 21 ASP B 335 TYR B 348 1 14 HELIX 22 22 SER B 370 ASN B 378 1 9 HELIX 23 23 PRO B 379 PHE B 381 5 3 HELIX 24 24 ASP B 382 PHE B 387 1 6 HELIX 25 25 GLY B 391 ASN B 400 1 10 HELIX 26 26 ASN B 400 PHE B 409 1 10 HELIX 27 27 THR B 443 LYS B 455 1 13 HELIX 28 28 PHE B 459 ASN B 464 1 6 HELIX 29 29 ASN B 468 CYS B 477 1 10 HELIX 30 30 VAL B 500 GLN B 505 5 6 HELIX 31 31 HIS B 506 TRP B 510 5 5 HELIX 32 32 TRP B 525 LYS B 530 1 6 HELIX 33 33 LYS B 530 ALA B 546 1 17 SHEET 1 AA16 LEU A 514 ILE A 519 0 SHEET 2 AA16 ALA A 488 ALA A 493 1 O ALA A 488 N LYS A 515 SHEET 3 AA16 VAL A 352 LEU A 358 1 O VAL A 355 N LEU A 489 SHEET 4 AA16 ALA A 329 HIS A 334 1 O ALA A 329 N ARG A 353 SHEET 5 AA16 ALA A 260 CYS A 264 1 O ALA A 260 N VAL A 330 SHEET 6 AA16 ARG A 287 ASP A 292 1 O ARG A 287 N VAL A 261 SHEET 7 AA16 VAL A 248 LEU A 255 -1 O HIS A 251 N ASP A 292 SHEET 8 AA16 SER A 238 LYS A 245 -1 O SER A 238 N GLU A 254 SHEET 9 AA16 SER B 238 THR B 243 -1 O HIS B 239 N TYR A 241 SHEET 10 AA16 ARG B 249 LEU B 255 -1 O LEU B 250 N VAL B 242 SHEET 11 AA16 ARG B 287 ASP B 292 -1 O VAL B 288 N LEU B 255 SHEET 12 AA16 ALA B 260 CYS B 264 1 O VAL B 261 N LEU B 289 SHEET 13 AA16 ALA B 329 HIS B 334 1 O VAL B 330 N CYS B 262 SHEET 14 AA16 VAL B 352 LEU B 358 1 N ARG B 353 O ALA B 329 SHEET 15 AA16 ALA B 488 ALA B 493 1 O LEU B 489 N SER B 357 SHEET 16 AA16 LEU B 514 ILE B 519 1 O LYS B 515 N MET B 490 CISPEP 1 PHE A 267 PRO A 268 0 -7.26 CISPEP 2 CYS A 423 GLU A 424 0 3.58 CISPEP 3 PHE B 267 PRO B 268 0 -6.44 SITE 1 AC1 8 PHE A 267 ASP A 335 TYR A 383 LEU A 408 SITE 2 AC1 8 MET A 419 TYR A 466 VAL A 498 HIS A 524 SITE 1 AC2 8 PHE B 267 ASP B 335 TYR B 383 LEU B 408 SITE 2 AC2 8 MET B 419 TYR B 466 VAL B 498 HIS B 524 CRYST1 47.690 79.870 88.610 90.00 89.95 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020969 0.000000 -0.000018 0.00000 SCALE2 0.000000 0.012520 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011285 0.00000